Nova Leap Health Corp (NLH.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 544 | 619 | 443 | 36 | 3 |
| Income taxes - deferred | -1,196 | 57 | -96 | -74 | -28 |
| Accounts receivable | 273 | -194 | -1,216 | -252 | -54 |
| Accounts payable and accrued liabilities | 4 | 18 | 471 | 99 | 0 |
| Other Working Capital | 648 | -77 | -958 | 185 | 0 |
| Other Operating Activity | 2,739 | 191 | -193 | -622 | -254 |
| Operating Cash Flow | $3,012 | $614 | $-1,550 | $-629 | $-333 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7 | -15 | -19 | N/A | N/A |
| Net Acquisitions | -1,613 | -978 | -6,336 | -1,800 | -240 |
| Other Investing Activity | 56 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,563 | $-993 | $-6,356 | $-1,800 | $-240 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 0 | 3,019 | 536 | 0 |
| Debt Issued | 681 | 1,768 | N/A | 0 | 197 |
| Debt Repayment | -1,580 | -1,377 | 0 | -186 | 0 |
| Common Stock Issued | N/A | 0 | 6,185 | 2,085 | 524 |
| Other Financing Activity | 574 | 340 | -151 | -18 | 0 |
| Financing Cash Flow | $-325 | $731 | $9,052 | $2,417 | $722 |
| Exchange Rate Effect | 20 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 1,635 | 1,284 | 137 | 148 | 0 |
| End Cash Position | 2,779 | 1,635 | 1,284 | 137 | 148 |
| Net Cash Flow | $1,124 | $352 | $1,147 | $-11 | $148 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,012 | 614 | -1,550 | -629 | -333 |
| Capital Expenditure | -7 | -15 | -19 | N/A | N/A |
| Free Cash Flow | 3,006 | 598 | -1,570 | -629 | -333 |